Pyxis Oncology PYXS
NASDAQ PYXS
$1.82 -0.02 (-1.36%)
As of: Oct 21, 2026 · 11:18 AM EDT

Pyxis Oncology (PYXS) Receivables - Net (2024 - 2025)

Updated

Pyxis Oncology (PYXS) posted Receivables - Net of $3 million for Q2 2025.

Analysis

Pyxis Oncology (PYXS) Receivables - Net (2024 - 2025) Analysis & Trends

  • The Q2 2025 figure stands as the highest quarterly Receivables - Net since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.67 Bn 1,100.26 Bn 19.71 Bn
2 Johnson & Johnson 614.28 Bn 532.81 Bn 17.26 Bn
3 AbbVie 503.23 Bn 476.34 Bn 12.70 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn
5 Novartis Ag 298.22 Bn 262.21 Bn 11.24 Bn
6 Astrazeneca 261.55 Bn 235.23 Bn 12.86 Bn
7 Amgen 235.92 Bn 191.31 Bn 7.24 Bn
8 Gilead Sciences 190.78 Bn 164.98 Bn 6.22 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn
10 Pyxis Oncology 116.14 Mn -148.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.00 Mn
Mar 31, 2024 8.00 Mn
API Access

Pyxis Oncology Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=PYXS&period=max&api_key=YOUR_API_KEY